These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacology of dantrolene sodium in children. Lietman PS; Haslam RH; Walcher JR Arch Phys Med Rehabil; 1974 Aug; 55(8):388-92. PubMed ID: 4853611 [No Abstract] [Full Text] [Related]
3. Letter: Treatment of spasticity in multiple sclerosis with dantrolene. Horne ML JAMA; 1976 Jan; 235(3):251. PubMed ID: 946040 [No Abstract] [Full Text] [Related]
4. Letter: Treatment of spasticity in multiple sclerosis with dantrolene. Tolosa ES; Soll RW; Loewenson RB JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254 [No Abstract] [Full Text] [Related]
5. Dantrolene sodium (Dantrium-Eaton) for relief of spasticity. Nelson JR West J Med; 1975 Aug; 123(2):131. PubMed ID: 1179721 [No Abstract] [Full Text] [Related]
6. Aggregation of dantrolene to human serum albumin. Capomacchia AC; Vallner JJ; Boone L J Pharm Sci; 1978 Jul; 67(7):1042-3. PubMed ID: 660502 [No Abstract] [Full Text] [Related]
7. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam. Schmidt RT; Lee RH; Spehlmann R Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625 [No Abstract] [Full Text] [Related]
8. Spasmolytic properties of dantrolene sodium: clinical evaluation. Sheplan L; Ishmael C Mil Med; 1975 Jan; 140(1):26-9. PubMed ID: 804674 [No Abstract] [Full Text] [Related]
9. [Endocrinologic features and the effect of dantrolene sodium in a subject with recurrent muscle spasms (author's transl)]. Takeuchi A; Kobayashi I; Nagasawa T; Nakazawa T; Inui S Nihon Naika Gakkai Zasshi; 1976 Aug; 65(8):778-84. PubMed ID: 988100 [No Abstract] [Full Text] [Related]
10. Treatment of spastic cerebral-palsied children with sodium dantrolene. Denhoff E; Feldman S; Smith MG; Litchman H; Holden W Dev Med Child Neurol; 1975 Dec; 17(6):736-42. PubMed ID: 1107103 [No Abstract] [Full Text] [Related]
12. Effect of dantrolene sodium on spasticity associated with hemiplegia. Steinberg FU; Ferguson KL J Am Geriatr Soc; 1975 Feb; 23(2):70-3. PubMed ID: 1141624 [TBL] [Abstract][Full Text] [Related]
13. A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Glass A; Hannah A Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209 [No Abstract] [Full Text] [Related]
14. Dantrolene sodium in children with spasticity. Haslam RH; Walcher JR; Lietman PS; Kallman CH; Mellits ED Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292 [No Abstract] [Full Text] [Related]
15. Dantrolene sodium: long-term effects in patients with muscle spasticity. Joynt RL Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122 [TBL] [Abstract][Full Text] [Related]
16. Spasticity and the effect of dantrolene sodium. Monster AW Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132 [No Abstract] [Full Text] [Related]
17. Dantrolene sodium: long-term effects in severe spasticity. Chyatte SB; Basmajian JV Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936 [No Abstract] [Full Text] [Related]
18. The effect of Dantrium on spasticity in spinal cord injuries. Jonsson B; Ladd H; Dahllöf AG Scand J Rehabil Med; 1975; 7(2):61-4. PubMed ID: 1162300 [TBL] [Abstract][Full Text] [Related]
19. Cooperative study for assessing the effects of a pharmacological agent on spasticity. Monster AW; Herman R; Meeks S; McHenry J Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384 [No Abstract] [Full Text] [Related]